Pabst Labs is opening a new manufacturing facility and distribution center dedicated to cannabis beverages in Desert Hot Springs, California.
The "cutting edge” facility will allow the company to more than triple its production capabilities.
According to Chuck Barlick, Pabst Labs' director of production, the goal is to leverage over twenty years of beverage manufacturing experience while establishing a standard for quality and efficiency that would set the bar in all cannabis-infused beverages facilities.
On top of its eponymous Pabst Blue Ribbon 10mg High Seltzer, the company also produces Not Your Father's Cannabis-Infused Root Beer and the St. Ides Cannabis product line.
Other brands will be allowed to access the facility through co-packaging relationships to help raise beverage quality and opportunity across the industry.
THC-infused beverages are seeing a 40 percent growth rate, the fastest-growing category in the cannabis industry, according to the Cannabis Beverage Association (CBA).
PBR High Seltzer is one of the top-selling THC-infused carbonated beverages in California.


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
The ghost of Robodebt – Federal Court rules billions of dollars in welfare debts must be recalculated
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 



